EPO and cancer: Potential mechanisms of elevated RDW in cancer patients may be that carcinogenesis is usually accompanied by increased inflammation, which causes inhibited response to erythropoietin, reduced iron release from reticuloendothelial macrophages, and shortened red blood cell survival through relevant inflammatory markers.